Walgreens Boots Alliance Past Earnings Performance

Past criteria checks 0/6

Walgreens Boots Alliance's earnings have been declining at an average annual rate of -50.6%, while the Consumer Retailing industry saw earnings growing at 18.9% annually. Revenues have been growing at an average rate of 3.3% per year.

Key information

-50.6%

Earnings growth rate

-50.3%

EPS growth rate

Consumer Retailing Industry Growth	18.8%
Revenue growth rate	3.3%
Return on equity	-126.8%
Net Margin	-5.8%
Last Earnings Update	31 Aug 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Walgreens Boots Alliance makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BATS-CHIXE:W8AD Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Aug 24	147,658	-8,636	26,315
31 May 24	145,533	-5,811	24,863
29 Feb 24	144,597	-6,037	25,198
30 Nov 23	142,406	574	24,880
31 Aug 23	139,081	-3,080	25,479
31 May 23	136,108	-3,315	25,412
28 Feb 23	133,291	-3,144	24,972
30 Nov 22	132,184	-2,964	24,912
31 Aug 22	132,703	4,337	24,994
31 May 22	134,516	5,111	25,925
28 Feb 22	135,948	5,926	25,542
30 Nov 21	134,972	5,965	24,865
31 Aug 21	132,509	1,994	23,798
31 May 21	128,617	1,972	23,305
28 Feb 21	124,952	-926	23,194
30 Nov 20	123,509	-981	23,052
31 Aug 20	121,982	179	22,836
31 May 20	125,566	519	23,676
29 Feb 20	129,792	3,339	24,269
30 Nov 19	132,984	3,628	24,521
31 Aug 19	120,074	3,816	23,183
31 May 19	136,354	4,817	25,135
28 Feb 19	136,097	5,133	25,112
30 Nov 18	134,590	5,326	25,065
31 Aug 18	131,537	5,024	24,638
31 May 18	128,244	4,314	23,745
28 Feb 18	124,028	4,134	23,520
30 Nov 17	120,453	3,845	23,067
31 Aug 17	118,214	4,078	23,618
31 May 17	116,701	4,306	23,115
28 Feb 17	116,081	4,247	23,046
30 Nov 16	116,819	4,117	23,302
31 Aug 16	117,351	4,173	23,425
31 May 16	117,237	3,169	23,409
29 Feb 16	116,534	3,368	23,433
30 Nov 15	112,923	4,480	22,996
31 Aug 15	103,444	4,220	21,669
31 May 15	93,979	3,973	20,224
28 Feb 15	84,585	3,385	18,611
30 Nov 14	77,617	2,059	17,661
31 Aug 14	76,392	1,932	17,691
31 May 14	75,276	2,810	17,684
28 Feb 14	74,188	2,720	17,579
30 Nov 13	73,230	2,760	17,473

Quality Earnings: W8AD is currently unprofitable.

Growing Profit Margin: W8AD is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: W8AD is unprofitable, and losses have increased over the past 5 years at a rate of 50.6% per year.

Accelerating Growth: Unable to compare W8AD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: W8AD is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (9.3%).

Return on Equity

High ROE: W8AD has a negative Return on Equity (-126.83%), as it is currently unprofitable.

Walgreens Boots Alliance Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

First quarter 2024 earnings released: US$0.078 loss per share (vs US$4.31 loss in 1Q 2023)

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Full year 2023 earnings released: US$3.57 loss per share (vs US$5.02 profit in FY 2022)

Recent updates

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Walgreens Announces Executive Appointments

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Second quarter dividend of US$0.25 announced

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

High number of new directors

New major risk - Financial position

High number of new directors

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

High number of new directors

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

Walgreens Boots Alliance, Inc. Announces Executive Changes

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

First quarter 2024 earnings released: US$0.078 loss per share (vs US$4.31 loss in 1Q 2023)

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Upcoming dividend of US$0.48 per share at 8.8% yield

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: US$3.57 loss per share (vs US$5.02 profit in FY 2022)

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

High number of new directors

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

CEO & Director recently bought €313k worth of stock

Second quarter 2023 earnings released: EPS: US$0.81 (vs US$1.02 in 2Q 2022)

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies